The metabolism of tramadol by human liver microsomes.
The metabolism of tramadol was investigated in vitro using microsomal fractions of human liver. The parent compound and its main metabolites were determined by a newly developed high performance liquid chromatography assay. O-demethylation of tramadol was found to be stereoselective. The Vmax of the O-demethylation of (-)-tramadol was 210 pmol.mg-1.min-1, whereas (+)-tramadol was O-demethylated with a Vmax of 125 pmol.mg-1.min-1. The Km for both enantiomers was determined to be 210 microM. O-demethylation was inhibited competitively by quinidine (ki = 15 nM) and propafenone (ki = 34 nM). N-demethylation was also stereoselective, preferentially metabolizing the (+)-enantiomer. Whereas O-demethylation displayed monophasic Michaelis-Menten kinetics, N-demethylation was best described by a two-site model. Competitive inhibition of the O-demethylation both by quinidine and propafenone suggests that O-demethylation is carried out by P-450IID6.
Paar
W D
WD
Zentrum für Innere Medizin-Allgemeine Innere Medizin, Universität Bonn.
Frankus
P
P
Dengler
H J
HJ
D006801:Humans; D066298:In Vitro Techniques; D008745:Methylation; D008862:Microsomes, Liver / Q000378:metabolism*; D014147:Tramadol / Q000378:metabolism*
D014147:Tramadol